blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3728310

EP3728310 - ANTIGEN BINDING POLYPEPTIDES [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  19.11.2021
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  25.09.2020
FormerThe international publication has been made
Status updated on  29.06.2019
Formerunknown
Status updated on  14.02.2019
Most recent event   Tooltip05.01.2024New entry: Decision on request for further processing 
Applicant(s)For all designated states
VIIV Healthcare UK (No.5) Limited
980 Great West Road
Brentford Middlesex TW8 9GS / GB
[2020/44]
Inventor(s)01 / KRYSTAL, Mark R.
36 E Industrial Road
Branford, Connecticut 06405 / US
02 / WENSEL, David L.
36 E Industrial Road
Branford, Connecticut 06405 / US
 [2020/44]
Representative(s)Drury, Elizabeth Anne
GSK
Legal & Compliance - Global Patents
79 New Oxford Street
London WC1A 1DG / GB
[N/P]
Former [2020/44]Drury, Elizabeth Anne
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date18842646.418.12.2018
[2020/44]
WO2018IB60271
Priority number, dateUS201762599902P18.12.2017         Original published format: US 201762599902 P
[2020/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019123262
Date:27.06.2019
Language:EN
[2019/26]
Type: A1 Application with search report 
No.:EP3728310
Date:28.10.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 27.06.2019 takes the place of the publication of the European patent application.
[2020/44]
Search report(s)International search report - published on:EP27.06.2019
ClassificationIPC:C07K16/10, C07K16/46, C07K16/28
[2020/44]
CPC:
C07K16/1063 (EP,US); C07K16/2812 (EP,US); C07K16/468 (EP,US);
A61K2039/505 (US); C07K2317/14 (US); C07K2317/31 (EP,US);
C07K2317/33 (EP); C07K2317/565 (US); C07K2317/76 (EP,US);
C07K2317/92 (EP); C07K2318/20 (EP,US); C07K2319/33 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/44]
TitleGerman:ANTIGENBINDENDE POLYPEPTIDE[2020/44]
English:ANTIGEN BINDING POLYPEPTIDES[2020/44]
French:POLYPEPTIDES DE LIAISON À UN ANTIGÈNE[2020/44]
Entry into regional phase22.06.2020National basic fee paid 
22.06.2020Designation fee(s) paid 
22.06.2020Examination fee paid 
Examination procedure17.10.2019Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.06.2020Amendment by applicant (claims and/or description)
22.06.2020Examination requested  [2020/44]
22.06.2020Date on which the examining division has become responsible
18.11.2021Despatch of a communication from the examining division (Time limit: M06)
20.05.2022Reply to a communication from the examining division
30.03.2023Despatch of a communication from the examining division (Time limit: M06)
03.11.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
20.12.2023Reply to a communication from the examining division
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
20.12.2023Request for further processing filed
20.12.2023Full payment received (date of receipt of payment)
Request granted
05.01.2024Decision despatched
Fees paidRenewal fee
09.12.2020Renewal fee patent year 03
16.12.2021Renewal fee patent year 04
20.12.2022Renewal fee patent year 05
19.12.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]WO2016171980  (BRISTOL MYERS SQUIBB CO [US]);
by applicantUS3773919
 USRE30985E
 US4560655
 US4657866
 US4767704
 US4927762
 US5122469
 WO9411026
 US5631144
 US5672502
 US6048728
 US6207446
 US6214553
 US6258558
 US6261804
 US6281344
 WO0204523
 US6518018
 US6818418
 US2005287153
 WO2006130834
 WO2009083804
 WO2009133208
 US7696320
 US2012121597
 WO2016000414
 US2016009789
 WO2016171980
 US9783703
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.